Recent development in application of high performance liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressantsZHENG YANG; SIHE WANG.Journal of immunological methods. 2008, Vol 336, Num 2, pp 98-103, issn 0022-1759, 6 p.Article

Lake Louise consensus conference on cyclosporin monitoring in organ transplantation : report of the consensus panelOELLERICH, M; ARMSTRONG, V. W; SCHÜTZ, E et al.Therapeutic drug monitoring. 1995, Vol 17, Num 6, pp 642-654, issn 0163-4356Conference Paper

Antifungal Therapeutic Drug Monitoring : Established and Emerging IndicationsANDES, David; PASCUAL, Andres; MARCHETTI, Oscar et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 1, pp 24-34, issn 0066-4804, 11 p.Article

International consensus conference on immunosuppressive drugsSOLDIN, Steven J; SHAW, Leslie M; YATSCOFF, Randall W et al.Therapeutic drug monitoring. 1995, Vol 17, Num 6, issn 0163-4356, 149 p.Conference Proceedings

International Congress of Therapeutic Drug Monitoring and Clinical ToxicologyTherapeutic drug monitoring. 2011, Vol 33, Num 4, pp 469-559, issn 0163-4356, 91 p.Conference Paper

Educational and Organizational Interventions to Improve the Usefulness of Clinical Pharmacological Advice for Personalized Drug Dosing Based on Therapeutic Drug MonitoringPEA, Federico; DOSE, Lucia; COJUTTI, Piergiorgio et al.Basic & clinical pharmacology & toxicology (Print). 2014, Vol 115, Num 5, pp 432-437, issn 1742-7835, 6 p.Article

International Congress of Therapeutic Drug Monitoring & Clinical ToxicologyTherapeutic drug monitoring. 2007, Vol 29, Num 4, pp 460-551, issn 0163-4356, 91 p.Conference Paper

Therapeutic drug monitoring of cyclosporin GYATSCOFF, R. W; LANGMAN, L; LEGATT, D. F et al.Therapeutic drug monitoring. 1995, Vol 17, Num 6, pp 655-659, issn 0163-4356Conference Paper

Therapeutic Drug Monitoring in Pediatrics: How Do Children Differ?MACLEOD, Stuart.Therapeutic drug monitoring. 2010, Vol 32, Num 3, pp 253-256, issn 0163-4356, 4 p.Conference Paper

Therapeutic Drug Monitoring in PregnancyMATSUI, Doreen M.Therapeutic drug monitoring. 2012, Vol 34, Num 5, pp 507-511, issn 0163-4356, 5 p.Article

Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: A kinetic analysisAURBEK, N; THIERMANN, H; EYER, F et al.Toxicology (Amsterdam). 2009, Vol 259, Num 3, pp 133-139, issn 0300-483X, 7 p.Article

Reliable HPLC method for therapeutic drug monitoring of frequently prescribed tricyclic and nontricyclic antidepressantsMALFARA, Wilson Roberto; BERTUCCI, Carlo; COSTA QUEIROZ, Maria Eugenia et al.Journal of pharmaceutical and biomedical analysis. 2007, Vol 44, Num 4, pp 955-962, issn 0731-7085, 8 p.Article

Dried blood spot liquid chromatography assay for therapeutic drug monitoring of metforminABURUZ, S; MILLERSHIP, J; MCELNAY, J et al.Journal of chromatography. B. 2006, Vol 832, Num 2, pp 202-207, issn 1570-0232, 6 p.Article

Interactions and Monitoring of Antipsychotic DrugsHIEMKE, Christoph; PFUHLMANN, Bruno.Handbook of experimental pharmacology. 2012, Vol 212, pp 241-265, issn 0171-2004, 25 p.Article

Influence of pre-analytical conditions on plasma ribavirin concentrationsGANDIA, Peggy; TRANCART, Stéphanie; NICOT, Florence et al.Arzneimittel-Forschung. 2010, Vol 60, Num 10, pp 636-639, issn 0004-4172, 4 p.Article

Individualisation des doses en oncoloqie : médicaments anticancéreux (2e partie) = Individual dosing in oncologyTHOMAS, Fabienne; CHATELUT, Etienne.La Lettre du pharmacologue (Boulogne). 2008, Vol 22, Num 3, pp 92-97, issn 0984-452X, 6 p.Article

The effect of multifactorial, multidisciplinary educational interventions on appropriate use of teicoplaninPEA, Federico; VIALE, Pierluigi; PAVAN, Federica et al.International journal of antimicrobial agents. 2006, Vol 27, Num 4, pp 344-350, issn 0924-8579, 7 p.Article

LC method for the therapeutic drug monitoring of lamotrigine : Evaluation of the assay performance and validation of its application in the routine areaZUFIA, L; ALDAZ, A; IBANEZ, N et al.Journal of pharmaceutical and biomedical analysis. 2009, Vol 49, Num 2, pp 547-553, issn 0731-7085, 7 p.Article

Pharmacokinetic-pharmacodynamic aspects of antimicrobial prophylaxis with teicoplanin in patients undergoing major vascular surgeryPEA, Federico; FURLANUT, Mario; VIALE, Pierluigi et al.International journal of antimicrobial agents. 2006, Vol 27, Num 1, pp 15-19, issn 0924-8579, 5 p.Article

Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapyGERVASINI, Guillermo; BENITEZ, Julio; CARRILLO, Juan Antonio et al.European journal of clinical pharmacology. 2010, Vol 66, Num 8, pp 755-774, issn 0031-6970, 20 p.Article

A HPLC-mass spectrometric method suitable for the therapeutic drug monitoring of everolimusTAYLOR, Paul J; FRANKLIN, Michael E; GRAHAM, Kendon S et al.Journal of chromatography. B. 2007, Vol 848, Num 2, pp 208-214, issn 1570-0232, 7 p.Article

Liquid chromatographic determination of unbound flecainide in therapeutic drug monitoringKATORI, Kumi; HOMMA, Masato; KUGA, Keisuke et al.Journal of pharmaceutical and biomedical analysis. 2003, Vol 32, Num 2, pp 375-380, issn 0731-7085, 6 p.Article

Suivi thérapeutique pharmacologique des antifongiques: de l'intérêt des dosages = Usefulness of therapeutic drug monitoring for autifungal agentsJULLIEN, V.La Lettre de l'infectiologue. 2013, Vol 28, Num 2, pp 60-64, issn 0296-9009, 5 p.Article

Suivi Thérapeutique Pharmacologique (STP)LIBERSA, Christian.Thérapie (Paris). 2010, Vol 65, Num 3, issn 0040-5957, 130 p.Serial Issue

Therapeutic drug monitoring of cyclosporineJORGA, A; HOLT, D. W; JOHNSTON, A et al.Transplantation proceedings. 2004, Vol 36, Num 2S, pp 396-403, issn 0041-1345, 8 p., SUPArticle